Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)
A very rare new type of adverse event called Thrombosis with Thrombocytopenia Syndrome (TTS), involving unusual and severe blood clotting events associated with low platelet counts, has been reported after vaccination with COVID-19 Vaccines Vaxzevria and Covishield.
10689
布莱顿协作组 1 正在制订血栓性血小板减少综合征的具体病例定义。
A specific case definition for TTS is being developed by the Brighton Collaboration 1 .
10690
这将有助于确定和评价报告的血栓性血小板减少综合征事件,并协助支持因果关系评估。
This will assist in identifying and evaluating reported TTS events and aid in supporting causality assessments.